Arian Mohammadi | Social and Cultural Neuroscience | Research Excellence Award

Published on by Neuroscientists

Mr. Arian Mohammadi | Social and Cultural Neuroscience | Research Excellence Award

University of Tehran | Iran

Arian is a graduate of the School of Urban and Regional Planning at the University of Tehran, with strong academic and professional training in urban planning, urban engineering, and data-driven decision-making for cities. He holds an M.Sc. in Urban Planning from the University of Tehran and a B.Sc. in Urban Engineering from the Iran University of Art, building a multidisciplinary foundation that integrates spatial planning, urban policy, and technological innovation. Arian has served as Lead for Data Science and Machine Learning in Urban Planning at the Puyashahr Think Tank, where he applies advanced analytical methods to address complex urban challenges. His professional experience includes working as a city planner at the Facilitation Office of Haftchenar–Beryanak in Region 10 of Tehran, as well as with the Tehran Office of Roads and Urban Development, contributing to community-based planning, urban regeneration, and development strategies. His research interests focus on smart mobility, urban analytics, and technology-enabled planning systems. He is currently developing a research manuscript on advancing ride-sharing services, providing a global review of emerging technologies and efficiency-enhancing initiatives. Through the integration of planning theory, data science, and applied urban practice, Arian’s work aims to support more inclusive, efficient, and resilient urban environments.

View Orcid Profile

Featured Publication

Public participation in urban regeneration using XAI-driven decision support system

Azizeh Farshbaf-Khalili | Molecular and Cellular Neuroscience | Excellence in Research Award

Published on by Neuroscientists

Assoc. Prof. Dr. Azizeh Farshbaf-Khalili | Molecular and Cellular Neuroscience | Excellence in Research Award

Tabriz University of Medical Sciences | Iran

Azizeh Farshbaf-Khalili, Ph.D., is an Associate Professor at Tabriz University of Medical Sciences and a senior researcher affiliated with the Physical Medicine and Rehabilitation Research Center and the Aging Research Institute. Her interdisciplinary academic background in nutrition and midwifery underpins a strong research focus on women’s health, nutrition-related outcomes, rehabilitation, aging, and translational health sciences. She has played a significant leadership role in academic development, having served in multiple senior positions including Vice Dean for Research, Vice Dean for Education, and Head of Education, Research, and Human Resources Development within university research and stem cell centers. Her scholarly output reflects sustained productivity and impact, with a substantial body of peer-reviewed publications indexed in major scientific databases. According to bibliometric indicators,recognition of her global research impact, she was named among the Top 2% of Scientists Worldwide by Stanford University in 2024 and 2025, reflecting her standing as a leading contributor to health and medical sciences.

Citation Metrics (Google Scholar)

3000
2500
2000
1500
0

Citations
2,825

Documents
161
h-index
30

Citations

Documents

h-index

View Google Scholar Profile

 

Featured Publications

Effects of zinc and magnesium supplements on postpartum depression and anxiety: A randomized controlled clinical trial

The effect of oral capsule of curcumin and vitamin E on hot flashes and anxiety in postmenopausal women: A triple-blind randomized controlled trial

Comparison of the effects of lanolin, peppermint, and dexpanthenol creams on treatment of traumatic nipples in breastfeeding mothers

Hendry Ramly | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Hendry Ramly | Clinical Neuroscience | Research Excellence Award

Fiona Stanley | Australia

Dr. Hendry Ramly is a clinician–researcher with advanced training in general medicine, cardiology, and intensive care medicine, and a focused academic interest in non-traumatic out-of-hospital cardiac arrest and post-resuscitation care. His research is directly informed by frontline clinical practice across acute medicine, ICU, and cardiology, where he manages critically ill patients following cardiac arrest. Dr. Ramly’s primary research examines cardiovascular management strategies after return of spontaneous circulation, with particular emphasis on haemodynamic stabilisation, coronary pathology, and the timing and utility of urgent coronary angiography. Neurological outcomes are included as standard clinical endpoints, while the central focus remains on cardiovascular determinants of survival and in-hospital mortality. He is lead author of a retrospective observational cohort study published in Heart, Lung and Circulation (2025), evaluating outcomes of non-traumatic out-of-hospital cardiac arrest at a tertiary centre. His additional audit work includes thoracic surgical outcomes, geriatric referral pathways, and procedural adequacy in respiratory medicine. Through clinically driven research and multidisciplinary collaboration, Dr. Ramly aims to refine evidence-based pathways that improve survival, decision-making, and quality of care for patients following cardiac arrest.


View ORCID Profile

Featured Publication

Joshua Barzilay | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Joshua Barzilay | Clinical Neuroscience | Best Researcher Award

Kaiser Permanente of Georgia, Emory School of Medicine | United States

Dr. Joshua I. Barzilay is a senior clinician–scientist and board-certified endocrinologist whose research spans diabetes, hypertension, cardiovascular disease, metabolic syndrome, and aging, integrating epidemiology with long-term clinical outcomes. His early work included oncology and hematology research, followed by a sustained focus on endocrine and metabolic disorders during his tenure at Kaiser Permanente of Georgia and Emory University School of Medicine. Dr. Barzilay has made influential contributions to large, multicenter clinical and population-based studies, including ALLHAT, ACCORD/ACCORDION, and the Cardiovascular Health Study, where he has served on steering committees and specialty working groups. His research has clarified the impact of glucose dysregulation, insulin resistance, and antihypertensive therapies on cardiovascular morbidity, mortality, and incident diabetes, particularly in older adults. A major theme of his work is the relationship between metabolic syndrome, frailty, autonomic function, and cardiovascular risk, providing evidence to guide treatment strategies in complex patients. In addition to his research, Dr. Barzilay has played a key role in national diabetes and hypertension guideline development, medical education, and dissemination of evidence-based care, shaping clinical practice across endocrinology and primary care.

Citation Metrics (Scopus)

25000
20000
15000
10000
0

Citations
24,155

Documents
186
h-index
58

Citations

Documents

h-index


View Scopus Profile
 View Google Scholar Profile

Featured Publications

Anant Bahadur Patel | Neurometabolism | Research Excellence Award

Published on by Neuroscientists

Prof. Dr. Anant Bahadur Patel | Neurometabolism | Research Excellence Award

CSIR-Centre for Cellular and Molecular Biology | India

Dr. Anant Bahadur Patel is a leading neuroscientist specializing in brain energy metabolism and neurotransmitter energetics using advanced in vivo and ex vivo ^13C NMR spectroscopy. His research focuses on understanding how excitatory (glutamatergic) and inhibitory (GABAergic) neuronal activity, together with astroglial metabolism, support brain function in health and disease. By combining stable ^13C-labeled substrates (glucose and acetate) with metabolic modeling, his work quantitatively measures neuronal and astrocytic metabolic fluxes across different brain regions. Dr. Patel has made seminal contributions by demonstrating the tight stoichiometric coupling between neurotransmitter cycling and oxidative glucose metabolism, challenging the astrocyte–neuron lactate shuttle hypothesis and establishing neuronal glucose oxidation as a primary energy source. His laboratory pioneered regional neurometabolic mapping in the mouse brain and clarified astrocytic contributions to cerebral energetics. A major thrust of his research addresses neurological and psychiatric disorders, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, depression, and addiction. He has identified early impairments in glutamate and GABA energetics as potential biomarkers for preclinical diagnosis and shown that neurometabolic deficits can be restored through pharmacological, dietary, and behavioral interventions. Overall, his work has significantly advanced quantitative neurometabolism and its translational relevance to brain disorders.

Citation Metrics (Scopus)

4000
3000
2000
1000
0

Citations
3,242

Documents
86
h-index
31

Citations

Documents

h-index


View Scopus Profile
 View ORCID Profile
 View Google Scholar Profile

Featured Publications

Hugo Libreros | Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Hugo Libreros | Neuroscience | Research Excellence Award

University of Arizona | United States

Hugo M. Libreros-Jiménez, Ph.D., is a mechatronic engineer and neuroscientist specializing in brain research with a strong technological and biomedical engineering orientation. He earned a Bachelor’s degree in Mechatronic Engineering with a focus on process automation from the Instituto Tecnológico Superior de Xalapa, followed by a Ph.D. in Brain Research (Health Sciences with a technological approach) from the Institute for Brain Research at the University of Veracruz. His research integrates neuroengineering, neuroelectronics, and automation applied to neuroscience, with particular emphasis on neural recording technologies, neuroendocrinology, and neurodevelopmental disorders. He has authored 2 peer-reviewed documents, published in NeuroSci, including works on cranial nerves and the neurobiological foundations of autism. His scholarly output has accumulated 14 citations, with an h-index of 1 and an i10-index of 1, reflecting emerging impact in interdisciplinary neuroscience research. His academic experience includes international research training in regenerative neurobiology and neuroelectronics, where he contributed to the development of platinized graphene fiber electrodes for simultaneous autonomic nerve recordings and supported graduate-level teaching in neural engineering methods. He has actively disseminated his research through oral and poster presentations at major national and international conferences in neuroscience and biomedical engineering, and he has contributed to the peer-review process as a reviewer for a physiology-focused scientific journal.

Citation Metrics (Google Scholar)

20
15
10
5
0

Citations
14

Documents
1

h-index
1

Citations

Documents

h-index

View Google Scholar Profile

Featured Publications

On the cranial nerves
HM Libreros-Jiménez, J Manzo, F Rojas-Durán, GE Aranda-Abreu, et al.NeuroSci, 5(1), 8–38
The Long and Winding Road to Understanding Autism
J Manzo, ME Hernández-Aguilar, MR Toledo-Cárdenas, et al.NeuroSci, 6(3), 84 ·

Xufeng Huang | Neuroscience of Obesity and Schizophrenia | Neuroscience Academic Excellence Award

Published on by Neuroscientists

Prof. Dr. Xufeng Huang | Neuroscience of Obesity and Schizophrenia | Neuroscience Academic Excellence Award

University of Wollongong | Australia

Professor Xufeng Huang is an internationally recognised molecular neuroscientist whose research integrates brain biology, metabolism, psychopharmacology, and nutritional science to address major public health challenges. His work has elucidated central molecular mechanisms of diet-induced obesity, including leptin resistance, neural injury, and cognitive decline, and translated these discoveries into preventive and therapeutic strategies. He has led pioneering research on antipsychotic-induced metabolic disorders in schizophrenia, identifying key neurotransmitter and receptor pathways and advancing safer pharmacological and adjunctive interventions. Professor Huang has also driven innovation in functional nutrition, notably the discovery and clinical validation of β-glucan as an effective dietary fibre for metabolic syndrome control, influencing dietary guidelines and policy. With extensive leadership of NHMRC-funded programs and international collaborations, his research spans mechanistic discovery, animal and human studies, and clinical translation. His contributions have shaped evidence-based interventions in brain health, obesity, metabolic disease, and severe mental illness, with sustained impact on clinical practice, policy development, and translational research across Australia and internationally.

Citation Metrics (Scopus)

16000
10000
6000
1000
0

Citations
14,714

Documents
349

h-index
66

Citations

Documents

h-index

View Scopus Profile View ORCID Profile View Google Scholar Profile

Featured Publications

Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice
– S Lin, TC Thomas, LH Storlien, XF Huang, International Journal of Obesity, 2000

Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression
– H Wang, LH Storlien, XF Huang, American Journal of Physiology–Endocrinology and Metabolism, 2002

Selective antagonist [3H] SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia
– K Zavitsanou, T Garrick, XF Huang, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2004

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
– CS Weickert, SJ Fung et al., Molecular Psychiatry, 2013

Gabriel Siquier-Dameto | Neuroscience of Pain and Analgesia | Innovative Research Award

Published on by Neuroscientists

Mr. Gabriel Siquier-Dameto | Neuroscience of Pain and Analgesia | Innovative Research Award

Mr. Gabriel Siquier-Dameto | Universidad de Girona | Spain

Gabriel Bernat Siquier Dameto is a Spanish researcher and medical professional whose work bridges clinical anatomy, neuroscience, and aesthetic medicine. Born in Palma de Mallorca and currently based in Campanet, he is affiliated with the Universitat de Girona, where he serves as a doctoral researcher within the Research Group of Clinical Anatomy, Embryology and Neuroscience (NEOMA) in the Department of Medical Sciences. Alongside his academic pursuits, he has developed a distinguished career as a medical director and aesthetic physician at Dameto Clinics International, contributing to the advancement of modern aesthetic practices. His expertise has led to influential roles as a Key Opinion Leader and worldwide trainer for leading biomedical and aesthetic technology companies, including RELIFE under the MENARINI Group and Suisselle S.A., as well as advisory work as a consultant for GLG. With recognized identifiers such as ORCID, ResearcherID, and ScopusID, Gabriel maintains an active scientific presence while integrating clinical knowledge with innovative aesthetic applications. His research interests and professional practice reflect a commitment to improving patient outcomes, advancing medical education, and promoting evidence-based aesthetic procedures, positioning him as a respected figure in both academic and clinical environments.

Profile: Orcid

Featured Publications

Siquier-Dameto, G., Gimeno-Beltrán, J., Bellia, G., Boadas-Vaello, P., & Verdú, E. (2025). Combined systemic and cutaneous ovalbumin–aluminum sensitization triggers thermal hyperalgesia, spinal gliosis, and nociceptive nerve fibers sprouting in mice. Physiologia, 5(3). doi:10.3390/physiologia5030032

Siquier-Dameto, G., Iguaran-Pérez, A., Gimeno-Beltrán, J., Bellia, G., Giori, A. M., Boadas-Vaello, P., & Verdú, E. (2025). Subcutaneous injection and brush application of ovalbumin–aluminum salt solution induces dermatitis-like changes in mice. Journal of Clinical Medicine, 14(5), 1701. doi:10.3390/jcm14051701

Siquier-Dameto, G., Boisnic, S., & Verdú, E. (2024). Revitalizing effect on the scalp after injection with a mechanically stabilized hyaluronic acid complex in subjects with androgenetic alopecia. Journal of Clinical Medicine, 13(22), 6878. doi:10.3390/jcm13226878

Siquier-Dameto, G., Boadas-Vaello, P., & Verdú, E. (2024). Intradermal treatment with a hyaluronic acid complex supplemented with amino acids and antioxidant vitamins improves cutaneous hydration and viscoelasticity in healthy subjects. Antioxidants, 13(7), 770. doi:10.3390/antiox13070770

Siquier-Dameto, G., Boisnic, S., Boadas-Vaello, P., & Verdú, E. (2023). Anti-aging and depigmentation effect of a hyaluronic acid mechanically stabilized complex on human skin explants. Polymers, 15(11), 2438. doi:10.3390/polym15112438

Tateo, A., Siquier-Dameto, G., Artzi, O., Humzah, D., Molina, B., Jain, R., Lanzarotti, A., Laouedj, M., Dapis, N., & Bellia, G. (2021). Development and validation of IBSA photographic scale for the assessment of neck laxity. Clinical, Cosmetic and Investigational Dermatology, 14, 1087–1097. doi:10.2147/CCID.S302860

Siquier-Dameto, G. (2020). Positive effect of hybrid stable cooperative complexes of high- and low-molecular-weight hyaluronic acid in psoriasis: A clinical series. Esperienze Dermatologiche. doi:10.23736/S1128-9155.21.00511-2

Adil el Housseini | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Adil el Housseini | Cellular Neuroscience | Best Researcher Award

Mr. Adil el Housseini | Ibn Zohr University Agadir Morocco | Morocco

Adil EL Housseini is a dedicated PhD candidate in biology at Ibn Zohr University, Faculty of Sciences of Agadir, specializing in toxicology, biochemistry, and the molecular characterization of scorpion venoms. His doctoral research explores the biochemical composition, ecotoxicity, and pathophysiological mechanisms of venoms from selected Buthid species, with a particular focus on developing novel therapeutic strategies for scorpion envenomation. Adil has contributed to the scientific community through peer-reviewed publications and authored book chapters spanning biomedical polymers, chitosan-based therapeutic applications, radioprotective biomaterials, and neurobiological insights into astrocyte function. His work on the kinetics of brain oxidative stress following scorpion envenomation highlights his strong command of experimental toxicology and neurobiochemical analysis. With an h-index of 1, two indexed documents, and two citations, he continues to build a research profile grounded in rigorous experimentation and interdisciplinary scientific inquiry. Adil’s skills include venom biochemistry, laboratory toxicology, data interpretation, and scientific writing, supported by strong language proficiency in Arabic, French, and English. His commitment to advancing knowledge in venom toxicology and biomedical sciences positions him as a promising emerging researcher contributing to both fundamental understanding and applied therapeutic innovation.

Profile: Google Scholar | Orcid

Featured Publications

Ait Hamdan, Y., Rhazi, M., El-Mansoury, B., Kabdy, H., Oukhrib, M., Ait Baba, A., … (2024). Astrocytes functions and their involvement in brain injury: A focus on the biomaterials’ role in mitigating traumatic brain injury. In Physiology and Function of Glial Cells in Health and Disease (pp. 145–163).

Mabsor-Zgandaoui, S., Rachmoune, K., Aftais, I., Elamrani, F. E., Amradi, I., … (2026). Biomedical polymers: Foundations and future innovations in medicine. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Ait Hamdan, Y., Armadi, I., Elamrani, F. E., Mekouar, M., El Housseini, A., … (2026). Therapeutic implications of chitosan and its derivatives: Focus on cancer treatment. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Rachmoune, K., Mabsor-Zgandaoui, S., El Housseini, A., Ait Hamdan, Y., … (2026). Radioprotective effects of chitosan polysaccharides and biomedical applications. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Armadi, I., Elouali, S., Abana, A., El Housseini, A., Loqman, S., & Belbachir, A. (2025). Overview of biomaterials classification, properties, and biomedical applications. In Innovations and Applications of Advanced Biomaterials in Healthcare 

Oleksandr Shapoval | Neuroimaging | Research Excellence Award

Published on by Neuroscientists

Dr. Oleksandr Shapoval | Neuroimaging | Research Excellence Award

Dr. Oleksandr Shapoval | Institute of Macromolecular Chemistry, Czech Academy of Sciences | Czech Republic

Dr. Oleksandr Shapoval, Ph.D., is a dedicated scientific researcher at the Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic in Prague, where he contributes to advanced developments in multimodal nanomarkers for complex microbial systems. His work centers on the synthesis, characterization, and functionalization of luminescent and magnetic nanoparticles, along with the design of functional colloids and nanosystems that serve as versatile multimodal imaging probes capable of immobilizing low-molecular-weight bioactive compounds and optimizing nanoparticle compatibility across diverse environments. He holds a Ph.D. in Chemistry with specialization in macromolecular compounds, complemented by degrees in administrative and financial management, as well as extensive training in chemical technology, fuel, and carbon materials. Over his career, Dr. Shapoval has established a strong academic presence, reflected in 136 citations, 17 published documents, and an h-index of 8, demonstrating the impact and quality of his scientific contributions. His multidisciplinary background and sustained research productivity position him as a valuable contributor to the field of nanosystems engineering, bridging chemistry, materials science, and bio-nanotechnology in ways that advance both theoretical understanding and practical application.

Profiles: Scopus | Orcid

Featured Publications

Vasylyshyn, T., Patsula, V., Větvička, D., Shapoval, O., Pankrác, J., Kabešová, M., Beneš, J., & Horák, D. (2025). Intraperitoneal versus intravenous administration of Flamma®-conjugated PEG-alendronate-coated upconversion nanoparticles in a mouse pancreatic cancer model. Nanoscale Advances.

Nahorniak, M., Horák, D., Šlouf, M., Steinhart, M., Shapoval, O., Engstová, H., & Ježek, P. (2025). Lanthanide-based UCNPs: Toxicity evaluation and interaction of ultrasmall core vs. core–shell nanoparticles with cells. Materials Advances.

Vasylyshyn, T., Huntošová, V., Patsula, V., Olejárová, S., Slabý, C., Jurašeková, Z., Bánó, G., Kubacková, J., Šlouf, M., Shapoval, O., et al. (2025). Surface-engineered core–shell upconversion nanoparticles for effective hypericin delivery and multimodal imaging. Nanoscale.

Shapoval, O., Patsula, V., Větvička, D., Šlouf, M., Kabešová, M., Vasylyshyn, T., Svobodová, L. M., Konefal, M., Kočková, O., Pankrác, J., et al. (2025). Theranostic verteporfin-conjugated upconversion nanoparticles for cancer treatment. Nanomaterials, 15(22), 1690.

Shapoval, O., Engstová, H., Šlouf, M., Kočková, O., Dlasková, A., Jabůrek, M., Halili, A., Mozheitová, A., Jirák, D., Ježek, P., et al. (2025). Liraglutide-conjugated poly(methyl vinyl ether-alt-maleic acid)-coated core–shell upconversion nanoparticles for theranostics of diabetes. ACS Applied Materials & Interfaces.